Antibiotic resistance is one of the greatest global health threats of our time. While developing new antibiotic drugs is one means of preventing unnecessary deaths from bacterial infections, the medtech sector has a pivotal role to play in ensuring that existing antibiotics are used responsibly.
Such could be the case for urinary tract infections (UTIs), which according to data provided by the National Institute for...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?